Research

Proud of our Team of Doctors

Publications, Presentations and Book Chapters

We are extremely proud of our Team of Doctors for participating and contributing their time and efforts in the following publications, presentations and book chapters.

List of Publications by Thomas A. Barnard, MD

“Metallic Intraocular Object Simulating Foreign Body” case report with Daniel T. Weidenthal, M.D.: American Journal of Ophthalmology, July 1998

“Bilateral Metastatic Menignococcal Endophthalmitis” case report with Arup Das, M.D., University of New Mexico: Archives of Ophthalmology, November 1997

“Endogenous Endophthalmitis” clinical case and literature review presented at Saint Luke’s Medical Center House Staff Science Day with Daniel T. Weidenthal, M.D., 1997

“Comparison of diabetic vs. pseudophakic disc staining, with Peter Pavan, M.D.; University of South Florida, 1992

“The addition of alkanes to 1-methylcyclohexene using Lewis acids”; under the direction of Theodore Beiler, Stetson University, 1987

“The Effects of 2.5% Neosynephrine versus 10% Neosynephrine on Systemic Blood Pressure and Heart Rate.” Presentation, Storm Eye Institute Annual Ophthalmology Update, April, 1991

List of Publications by Matthew A. Cunningham, MD

A complete list of all publications

Cunningham MA, Tlucek P, Folk JC, Boldt HC, Russell SR. Acute, non-infectious uveitis subsequent to both intravitreal bevacizumab and ranibizumab injections. Retinal Cases and Brief Reports. 2013; 7(4):355-358. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932495/

Cunningham MA, Tarantola R, Folk JC, Sohn EH, Boldt HC, Graff JA, Elkins K, Russell SR, Mahajan VB. Proliferative Vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases. Retina. 2013 Mar; 33(3):579-85. http://www.ncbi.nlm.nih.gov/pubmed/23222494

Cunningham MA, Boldt HC, Stone EM. Retinal detachment in a patient with Leber’s Congenital Amaurosis. Retinal Cases and Brief Reports. 2013; 7(1): 102-4. http://www.ncbi.nlm.nih.gov/pubmed/25390536

Cunningham MA, Li Z, Liu B, Yeh S, Nussenblatt RB. OX40 ligand (OX40L) expression abrogates the immunosuppressive function of retinal pigment epithelium. Journal of Ophthalmic Inflammation and Infection. 2013, 3:12. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605066/

Cunningham MA, Alexander JK, Wilhelmus KR, Matoba AY, Jones DB. Management and Outcomes of Anterior Microbial Scleritis. Cornea. 2011 Sep;30(9):1020-3. http://www.ncbi.nlm.nih.gov/pubmed/21694595

Zheng X, Ma P, De Paiva CS, Cunningham MA, Hwang CS, Pflugfelder SC, Li DQ. TSLP and Downstream Molecules in Experimental Mouse Allergic Conjunctivitis. Invest Ophthalmol Vis Sci 2010 Jun;51(6):3076-82.

Yeh S, Cunningham MA, Patronas N, Foroozan R. “Optic neuropathy and perichiasmal tuberculomas associated with Mycobacterium tuberculosis meningitis in pregnancy.” Can J Ophthalmol 2009; 44:713–5.

Cunningham MA, Foroozan RF. “A 69 year-old man with decreased vision and abnormal visual field.” Medscape Ophthalmology Interactive Case Series. Posted on 7/2009. (http://www.medscape.com/viewarticle/705208)

Yeh S, Li Z, Forooghian F, Hwang FS, Cunningham MA, Pantanelli S, Lew J, Wroblewski K, Vitale S, Nussenblatt RB. “CD4+ Foxp3+ T-regulatory cells in non-infectious uveitis” Arch Ophthalmol. 2009; 127(4): 407-413.

Cunningham MA, Austin BA, Li Z, Liu B, Yeh S, Chan CC, Anglade E, Velagaleti P, Nussenblatt RB. “LX211 (Voclosporin) Suppresses Experimental Uveitis and Inhibits Human T Cells.” Invest Ophthalmol Vis Sci. Jan 2009; 50: 249-255.

Cunningham MA, Edelman JL, Kaushal S. “Intravitreal Steroids for Macular Edema: the past, the present, and the future.” Survey of Ophthalmology. 2008 Mar-Apr;53(2):139-149.

Cunningham MA, Peden M, Downer D, Ratnakaram R. Bilateral retinochoroiditis in a case of acute primary toxoplasmosis in an immunocompetent patient. Digital Journal of Ophthalmology 2006; Volume 12: Number 2. (http://www.djo.harvard.edu/site.php?url=/physicians/oa/982)

PRESENTATIONS

David RP Almeida, Zaid Mammo, Eric K Chin, Matthew Cunningham & Vinit B Mahajan, Acanthamoeba Panuveitis, Ocular Imaging Conference, Las Vegas, United States, paper session at American Academy of Ophthalmology. November 2015.

MA Cunningham. Navigating the Retinal seas: a review of common retinal pathology. Oral presentation for Central Florida Society of Optometric Physicians meeting. January 13, 2015.

MA Cunningham. Review of Anti-VEGF Intravitreal Injections: Types, Common Indications, and Cases. Oral presentation for Central Florida Society of Optometric Physicians meeting. January 14, 2014.

MA Cunningham. Acute optical coherence tomography changes over involuted choroidal neovascularization in the presumed ocular histoplasmosis syndrome. Oral presentation at University of Iowa Department of Ophthalmology Resident/Fellow Research Day, May 2013.

James Folk, Matthew Cunningham, Elliott Sohn, Michael Abramoff. Activated Histoplasmosis Scars. Paper presentation at Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, May 6, 2013.

James Folk, Matthew Cunningham, Elliott Sohn, Michael Abramoff. Activated Histoplasmosis Scars. Paper presentation at the Macula Society. Session IX: Uveitis and Tumors. Friday, March 1, 2013. Dana Point, CA.

MA Cunningham, R Tarantola, JC Folk, EH Sohn, HC Boldt, JA Graff, KA Elkins, SR Russell, VB Mahajan. “Macular Hole Closure in Combined Rhegmatogenous Retinal Detachment” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL May 8, 2012.

MA Cunningham, L Zhang, DQ Li, S Pflugfelder. “Goblet cell density in the murine allergic conjunctivitis model.” Oral presentation at 48th Annual Cullen Eye Institute, BCM Department of Ophthalmology Alumni Meeting, June 2011.

MA Cunningham, B Chan-Kai, PE Carvounis. “Visual and Anatomic Outcomes with Pars Plana Vitrectomy for Non-Clearing Vitreous Hemorrhage” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL May 5, 2011.

MA Cunningham. “Management and Outcome of Microbial Scleritis.” Oral presentation at National Medical Association Meeting, Orlando, FL August 2010.

MA Cunningham, KR Wilhelmus, AY Matoba, DB Jones. “Management and Outcome of Microbial Scleritis.” Oral presentation at 47th Annual Cullen Eye Institute, BCM Department of Ophthalmology Alumni Meeting, June 2010.

MA Cunningham, DQ Li, L Zhang, SC Pflugfelder. “Epithelial-Derived Cytokines (TSLP and IL-33) May Regulate Ocular Surface Inflammation in Atopic Patients” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL May 5, 2010.

MA Cunningham. Ocular Rosacea: The past, the present, and the future. Oral presentation at Cullen Eye Institute, Cornea Section Conference, 2009.

MA Cunningham, SC Pflugfelder. “OX40 Ligand (OX40L) in the Pathogenesis of the Experimental Murine Allergic Conjunctivitis Model.” Oral presentation at 46th Annual Cullen Eye Institute, BCM Department of Ophthalmology Alumni Meeting, June 2009.

MA Cunningham, PE Carvounis, ER Holz. “Intravitreal Anti-VEGF Injections for Choroidal and Retinovascular Diseases in Patients Following Trabeculectomy.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL May 3, 2009.

MA Cunningham, Z Li, B Liu, SP Mahesh, R Nussenblatt. “OX40 Ligand (OX40L) and Its Potential Role in Ocular Inflammation: An in vitro approach.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL April 29, 2008.

BA Austin, MA Cunningham, Z Li, B Liu, CC Chan, S Yeh, P Velagaleti, RB Nussenblatt. “LX211 (ISA247) Suppresses Anti-CD3 Activated Human T-Cell Proliferation and Effectively Treats Experimental Autoimmune Uveitis in Rats.” Poster presentation at Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL April 30, 2008.

MA Cunningham, Z Li, CC Chan, B Liu, S Pantanelli, S Yeh, E Anglade, P Velagaleti, D Trapenier, RB Nussenblatt. “Subcutaneous Injections of LX211 Prevent and Reverse Experimental Autoimmune Uveoretinitis in Rats.” Poster presentations at University of Florida Medical Student Research Day, Gainesville, FL March 26, 2007 & Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL May 8, 2007.

Cunningham MA, Goldberger BA, Graham N, Gold MS. “Cocaine – A Recurring Epidemic in Florida?” Poster presentation at Society for Neuroscience, Atlanta, Georgia, October, 2006.

Cunningham MA, Goldberger BA, Graham N, Gold MS. “Cocaine Abuse in 2006- A New Epidemic?” Poster presentation at American Academy of Addiction Psychiatry, St. Pete Beach, FL, 2006.

Cunningham, M. Malignant Degeneration in Ollier’s Disease: A Retrospective Chart Review of 21 patients. Oral Presentation at Medical Student Research Day, Gainesville, FL March, 2004.

BOOK CHAPTERS

Cunningham MA, Boldt HC. Clinical features and diagnosis of retinoblastoma. In: Retinoblastoma: Clinical Advances and Emerging Treatment Strategies. Murray TG (Ed.). Future Medicine, London, UK. eISBN 978-1-78084-204-2. Pages 24-34. http://www.futuremedicine.com/doi/book/10.2217/9781780842042

Cunningham MA. Acute vision loss in children. In: Caring for the Hospitalized Child: A Handbook of Inpatient Pediatrics.Editors: Daniel Rauch, Jeffrey Gershel. American Academy of Pediatrics, 2013. http://www.amazon.com/Caring-Hospitalized-Child-Inpatient-Pediatrics/dp/1581107544

Cunningham MA, Yeh S. Birdshot Chorioretinopathy (vitiliginous chorioretinitis). In: The Wills Eye Clinical Synopsis and Color Atlas: Ocular Inflammatory Disease. Editors: Sunir Garg, Nida Sen, Bahram Bodaghi, Robert Nussenblatt. Lippincott Williams & Wilkins, 2011. http://www.amazon.com/Color-Atlas-Synopsis-Clinical-Ophthalmology/dp/1451101465

List of Publications by William J. Dunn, MD, FACS, CHE

“Botulinum Toxin for Dysthyroid Myopathy.” Dunn, W.J., Arnold, A.C., O’Connor, P.S. Ophthalmology, April, 1986, p470-475. Paper presented at American Academy of Ophthalmology Annual Meeting, San Francisco, October 1985

“Choroidal Malignant Melanoma with Early Vitreous Seeding.” Dunn, W.J., Lambert, H.M., Kincaid, M.C., Dieckert, J.P., Shore, J.W. Retina, 1988, Volume 8, Number 3, p 188-192

List of Publications by S.K. Steven Houston III, MD

Publications - Peer-reviewed

Mehta R, Ying GS, Houston S, Isakova T, Nessel L, Ojo A, Go A, Lash J, Kusek J, Grunwald J, Wolf M. Phosphate, Fibroblast Growth Factor 23 and Retinopathy in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2015; In Press.

Chen X, Rahimy E, Sergott RC, Nunes RP, Souza EC, Choudhry N, Cutler NE, Houston SK, Munk MR, Fawzi AA, Mehta S, Hubschman JP, Ho AC, Sarraf D. Spectrum of retinal vascular diseases associated with paracentral acute middle maculopathy. Am J Ophthalmol 2015 [epub ahead of print].

Houston SK, Rayess NM, Cohen M, Ho AC, Regillo CD. Influence of vitreomacular interface on anti-VEGF therapy using treat and extend treatment protocol for age-related macular degeneration (VINTREX). RETINA 2015; in press.

Williams AL, Greven M, Houston SK, Mehta S. Saturday night retinopathy: case report and a review of the literature. JAMA Ophthalmol 2015; in press.

Juhn AT, Houston SK, Mehta S. Bilateral Straatsma Syndrome with nystagmus. Retinal Cases and Brief Reports 2015; in press.

Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho AC, Regillo CD. Efficacy of intravitreal Ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol 2015 [epub ahead of print].

Rayess NM, Houston SK, Gupta OP, Ho AC, Regillo CD. Three year treatment outcomes for neovascular age-related macular degeneration using a "treat and extend" regimen. Am J Ophthalmol 2015;159(1):3-8.

Shah NV, Pham D, Murray TG, Decatur C, Hernandez E, Shah NN, Cavalcante M, Houston SK. Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice. J Ophthalmol 2014;epub 2014.

Shah NV, Houston SK, Markoe AM, Murray TG. Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma. Clin Ophthalmol 2013;7:1877-1882.

Houston SK, Lonngi M, Murray TG. Surgical management of posterior uveal melanoma: trends and developments. Exp Rev Ophthalmol 2013;8(4):393-99.

Shah NV, Houston SK, Murray TG. Retinoblastoma and treatment: a current evaluation of advanced therapy. World J Pharmacol 2013; 2(3):65-72.

Houston SK, Murray TG, Lampidis TJ. Models and discovery in retinoblastoma. Expert Opin Drug Discov 2013;8(4):383-94.

Houston SK, Shah NV, Decatur C, Lonngi M, Feuer W, Markoe AM, Murray TG. Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances the resolution of exudative detachment. Clin Ophthalmol 2013;7:193-8.

Lonngi M, Houston SK, Murray TG, et al. Microincisional vitrectomy for retinal detachment in I-125 brachytherapy treated patients with posterior uveal malignant melanoma. Clin Ophthalmol 2013;7:427-35.

Shah NV, Houston SK, Markoe AM, Feuer W, Murray TG. Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity. Clin Ophthalmol 2012;6:1739-48.

Steven Houston SK, Shah NV, Murray TG. Intraoperative ultrasound aids plaque positioning. Ophthalmology 2012;119(11):2419-20.

Parke III DW, Sisk RA, Houston SK, Murray TG. Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification. Clin Ophthalmol 2012;6:925-931.

Pina Y, Houston SK, Murray TG, Koru-Sengul T, Decatur C, Scott WK, Nathanson L, Clarke J, Lampidis TJ. Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-D-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors. Clin Ophthalmol 2012;6:817-30.

Shah NV, Houston SK, Murray TG, Markoe AM. Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review. Clin Ophthalmol 2012;6:447-52.

Houston SK, Wykoff CC, Berrocal AM, Hess DJ, Murray TG. Lasers for the treatment of intraocular tumors. Lasers Med Sci 2012; Feb 3 [epub ahead of print].

Pina Y, Decatur C, Murray TG, Houston SK, Lopez-Cavalcante M, et al. Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FDG), to target the chemoresistive hypoxic regions in LH(BETA)T(AG) retinal tumors. Invest Ophthalmol Vis Sci 2012;53(2):996-1002.

Houston SK, Murray TG. Microarray gene-expression analysis in ocular oncology: uveal melanoma and retinoblastoma. Expert Rev Ophthalmol 2011;6(4):477-85.

Houston SK, Wykoff CC, Berrocal AM, Hess DJ, Murray TG. Laser treatment for retinopathy of prematurity. Lasers Med Sci 2011; Dec 2 [epub ahead of print].

Houston SK, Markoe AM, Boldt HC, Murray TG. Juxtapapillary uveal melanomas: patient outcomes after treatment with proton irradiation for peripapillary and parapapillary melanomas (Editorial). Arch Ophthalmol 2011;129(9):1218-20.

Houston SK, Pina Y, Murray TG, et al. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors. Invest Ophthalmol Vis Sci 2011; 52(8):5359-68.

Houston SK, Berrocal AM, Murray TG. The future of diagnostic imaging in retinoblastoma. JAAPOS 2011; 15(2): 125-6.

Pina Y, Decatur C, Murray TG, Houston SK, et al. Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors. Clin Ophthalmol 2011; 5: 337-43.

Wykoff CC, Houston SK, et al. Anti-vascular endothelial growth factor agents for pediatric retinal diseases. Int Ophthalmol Clin 2011;51(1): 185-99.

Houston SK, Murray TG, et al. Current Update on Retinoblastoma. Int Ophthalmol Clin 2011; 51(1): 77-91.

Houston SK, Pina Y, Murray TG, et al. Novel Retinoblastoma treatment avoids chemotherapy: The effect of optimally-timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors. Clin Ophthalmol 2011; 27(5): 129-37.

Pina Y, Houston SK, Murray TG, et al. Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma. Invest Ophthalmol Vis Sci 2010; 51(12): 6149-56.

Pina Y, et al., Houston SK (6th author) – Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin of advanced retinoblastoma. J Pediatr Ophthalmol Strabismus 2010; Sep 22; 47 Online: e1-5.

Steven Houston SK, Ghazi NG, Morgan O, Olsakovsky L, Phillips P. A novel approach to processing DSAEK specimens for histopathologic analysis. Cornea 2010; 29(12): 1452-4.

Steven Houston SK, Weber ED, Koga SF, Newman SA. Novel applications of rarebit perimetry. J Neuroophthalmol 2010; 30(3): 243-7.

Houston SK, Ghazi NG, Bourne TD, Lopes MB. Bilateral massive retinal gliosis associated with Retinopathy of Prematurity. Arch Pathol Lab Med 2009; 133(8): 1242-45.

Presentations

Houston SK, Rayess NM, Cohen M, Ho AC, Regillo CD. Influence of vitreomacular interface on anti-VEGF therapy using treat and extend treatment protocol for age-related macular degeneration (VINTREX). Paper presentation at Retina Society, Philadelphia, PA, September 2014.

Rayess NM, Houston SK, Ho AC, Regillo CD. Long term treatment outcomes for neovascular age-related macular degeneration using a "treat and extend" regimen. Paper presentation at Retina Society, Philadelphia, PA, September 2014.

Chiang A, Houston SK, Juhn AT, Cohen M, Vander J, Regillo CD, Ho AC. Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion. Paper presentation at Retina Society, Philadelphia, PA, September 2014.

Houston SK, Rayess NM, Cohen M, Ho AC, Regillo CD. Influence of vitreomacular interface on anti-VEGF therapy using treat and extend treatment protocol for age-related macular degeneration (VINTREX). Paper presentation at American Society of Retina Specialists (ASRS) annual meeting, San Diego, CA, August 2014.

Regillo CD, Rayess NM, Houston SK, Ho AC. Long term treatment outcomes for neovascular age-related macular degeneration using a "treat and extend" regimen. Paper presentation at American Society of Retina Specialists (ASRS) annual meeting, San Diego, CA, August 2014.

Cohen M, Houston SK, Juhn AT, Chiang A, Vander J, Regillo CD, Ho AC. Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion. Poster presentation at American Society of Retina Specialists (ASRS) annual meeting, San Diego, CA, August 2014.

Shah NV, Houston SK, Markoe AM, Murray TG. Incidence of radiation retinopathy in patients with uveal melanoma treated with I-125 plaque brachytherapy at a single institution. American Academy of Ophthalmology (AAO) annual meeting, poster presentation 2013.

Houston SK, Shah N, Decatur CL, Lonngi M, Feuer WJ, Murray TG. Intravitreal bevacizumab as an adjuvant agent to plaque brachytherapy reduces tumor burden and enhances the resolution of exudative detachment. Association for Research in Vision and Ophthalmology (ARVO) poster 2012.

Shah N, Houston SK, Feuer WJ, Murray TJ. Effect of early SD-OCT diagnosis followed by prompt treatment of radiation retinopathy with anti-VEGF agents on visual acuity. Association for Research in Vision and Ophthalmology (ARVO) poster 2012.

Lonngi M, Murray TG, Sisk RA, Parke III DW, Berrocal AM, Houston SK. Combined microincisional vitrectomy and phacoemulsification in the management of complications associated with 125-I brachytherapy treated patients with uveal malignant melanoma. Association for Research in Vision and Ophthalmology (ARVO) poster 2012.

Cavalcante ML, Shah NV, Houston SK, Murray TG, Markoe AM. Evaluation of learning curve for 125-Iodine plaque brachytherapy placement: a 19 year review. Association for Research in Vision and Ophthalmology (ARVO) poster 2012.

Decatur CL, Shah N, Pina Y, Lonngi M, Pham D, Houston SK, Murray TG. Use of AMP-kinase activator 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) in the treatment of retinoblastoma. Association for Research in Vision and Ophthalmology (ARVO) poster 2012.

Shah NN, Houston SK, Pina Y, Murray TG, Decatur CL, Merchan J, Lampidis T. 2-deoxy-D-glucose (2-DG): In vivo evaluation of anti-angiogenic impact on retinoblastoma tumor vasculature. Association for Research in Vision and Ophthalmology (ARVO) poster 2012.

Houston SK, Murray TG, Pina Y, Decatur C. Treatment of LH(BETA)T(AG) retinoblastoma tumors with angiogenic and glycolytic inhibitors avoids chemotherapy. International Society of Ocular Oncology (ISOO) presentation 2011.

Houston SK, Murray TG, Markoe AM, Pina Y, Decatur C. Intravitreal bevacizumab as an adjuvant agent when used immediately after treatment with plaque brachytherapy. International Society of Ocular Oncology (ISOO) presentation 2011.

Pina Y, Decatur C, Houston SK, Murray TG, Cavalcante L, Lampidis T. Using the glycolytic inhibitor 2-fluorodeoxy-D-glucose, a novel approach to target the chemoresistant cell population in LH(BETA)T(AG) retinal tumors. International Society of Ocular Oncology (ISOO) presentation 2011.

Murray TG, Pina Y, Decatur CL, Houston SK, Cavalcante L, Lampidis L. mTOR targeting in combination with chemotherapy: upstream regulation of anaerobic glycolysis to target the chemoresistant cell population in RB. International Society of Ocular Oncology (ISOO) presentation 2011.

Murray TG, Houston SK, Aziz-Sultan MA, Fernandes CE, Decatur C, Pina Y. Intra-arterial melphalan dosing regimens for the treatment of retinoblastoma. International Society of Ocular Oncology (ISOO) presentation 2011.

Decatur C, Pina Y, Houston SK, Cavalcante L, Lampidis T, Murray TG. A novel, oral, non-invasive method of delivery for the glycolytic inhibitor 2-deoxy-D-glucose in the treatment of retinoblastoma. International Society of Ocular Oncology (ISOO) presentation 2011.

Murray TG, Houston SK, Decatur CL, Shah N, Cavalcante L, Pina L. Treatment modulation in retinoblastoma tumorigenesis and its impact on tumor burden. International Society of Ocular Oncology (ISOO) poster 2011.

Decatur CL, Pina Y, Houston SK, Sullivan E, Liu H, Lampidis T, Murray TG. Evaluating the glycolytic pathway in retinoblastoma: a mechanistic approach using the glycolytic inhibitor 2-deoxy-D-glucose in vitro and in vivo. International Society of Ocular Oncology (ISOO) poster 2011.

Pina Y, Murray TG, Decatur CL, Shah N, Cavalcante L, Houston SK. Regional and temporal variations in gene expression and vasculature during retinoblastoma tumorigenesis and its impact on ocular treatment. International Society of Ocular Oncology (ISOO) poster 2011.

Murray TG, Houston SK, Aziz-Sultan MA, Fernandes CE. Strategies for chemotherapeutic dosing utilizing intra-arterial melphalan chemotherapy for primary and rescue treatment for pediatric retinoblastoma. ASRS presentation 2011.

Houston SK, Murray TG, Decatur CL, Pina Y, Cavalcante L, Lampidis T. Use of 2-fluorodeoxy-D-glucose (2-FDG) to target the chemoresistant, hypoxic cell population in advanced LH(BETA)T(AG) retinal tumors. Association for Research in Vision and Ophthalmology (ARVO) poster 2011.

Pina Y, Decatur CL, Houston SK, Cavalcante L, Lampidis T, Murray TG. Mammalian target of rapamycin in combination with chemotherapy: upstream regulation of anaerobic glycolysis to target the chemoresistant cell population in retinoblastoma. Association for Research in Vision and Ophthalmology (ARVO) poster 2011.

Decatur CL, Pina Y, Houston SK, Cavalcante L, Murray TG, Lampidis T. Evaluating the glycolytic pathway in retinoblastoma: a molecular mechanistic approach using the glycolytic inhibitor 2-deoxy-D-glucose in vitro and in vivo. Association for Research in Vision and Ophthalmology (ARVO) poster 2011.

Murray TG, Decatur CL, Pina Y, Houston SK, Cavalcante L, Lampidis T. A novel, oral, non-invasive method of delivery for the glycolytic inhibitor 2-deoxy-D-glucose in the treatment of retinoblastoma. Association for Research in Vision and Ophthalmology (ARVO) poster 2011.

Houston SK, Decatur CL, Murray TG, Shah N, Cavalcante L, Pina Y. Novel treatment approaches in retinoblastoma: impact of combination therapy on tumor burden. American Association of Cancer Research (AACR) poster 2011.

Murray TG, Pina Y, Decatur CL, Houston SK. Anti-angiogenic agents combined with chemotherapy targets tumor vasculature and decreases tumor burden. American Association of Cancer Research (AACR) poster 2011.

Pina Y, Murray TG, Houston SK, Decatur CL. Tumor associated macrophages as potential targets in retinoblastoma tumors. American Association of Cancer Research (AACR) poster 2011.

Decatur CL, Pina Y, Houston SK, Murray TG. Non-invasive, oral 2-deoxy-D-glucose (2-DG) reduces tumor burden and hypoxia in LH(BETA)T(AG) retinoblastoma tumors. American Association of Cancer Research (AACR) poster 2011.

Houston SK, Pina Y, Scott WK, Nathanson L, Schefler AC, Murray TG. Regional and temporal differences in the genetic expression of LH(BETA)T(AG) retinoblastoma tumors. Association for Research in Vision and Ophthalmology (ARVO) poster 2010.

Pina Y, Houston SK, Scott W, Nathanson L, Schefler AC, Lampidis T, Celdran M, Hernandez E, Murray TG. Retinoblastoma molecular genomics: regional differences in the molecular genomics expression following treatment with 2-deoxy-D-glucose in LH(BETA)T(AG) retinal tumors. Association for Research in Vision and Ophthalmology (ARVO) presentation 2010.

Murray TG, Pina Y, Houston SK, Hernandez E, Celdran M, Feuer W, Lampidis T. Retinoblastoma tumor burden control: periocular mTOR inhibitor rapamycin decreases tumor burden in advanced LH(BETA)T(AG) murine retinoblastoma. Association for Research in Vision and Ophthalmology (ARVO) poster 2010.

Green DP, Houston SK, Newman SA. Rarebit perimetry: number of test passes needed to identify visual field defects. Association for Research in Vision and Ophthalmology (ARVO) poster 2010.

Berrocal AM, Houston SK, Pina Y, Bascom Palmer Imaging Group, Murray TG. Intraoperative spectral domain optical coherence tomography (SD-OCT) imaging of complex pediatric retinal disease. Association for Research in Vision and Ophthalmology (ARVO) presentation 2010.

Houston SK, Weber ED, Newman SA, Koga SF. Novel applications of rarebit perimetry. Association for Research in Vision and Ophthalmology (ARVO) poster 2009.

Houston SK, Ghazi NG. Bilateral massive retinal gliosis in a patient with bilateral retinal detachment in the setting of retinopathy of prematurity. Association for Research in Vision and Ophthalmology (ARVO) poster 2008.

Book Chapters

Houston SK, Ho AC. Miscellaneous Macular Degenerations. Ed: Scott IU, Regillo CD, Flynn HW, Brown GC. Vitreoretinal Diseases: The Essentials 2014 (in press).

Houston SK, Garg SJ. Fundus photography and autofluorescence in AMD. Ed: A. Witkins Age-related Macular Degeneration 2014 (in press).

Houston SK, Markoe AM, Boldt HC, Murray TG. Brachytherapy for uveal melanoma. In: Ryan SJ, ed. RETINA, 5th edition. Philadelphia, PA: Elsevier/Mosby, 2012: Chapter 145.

Houston SK, Pina Y, Murray TG. Future Trends in Retinoblastoma. In: Ramasubramanian A, Shields C, ed. Retinoblastoma, 1st edition. Panama: Jaypee-Highlights Medical Publishers, Inc., 2012: Chapter 36.

Houston SK, Murray TG. Chapter 2: Laboratory Discoveries. Retinoblastoma: Clinical advances and emerging treatment strategies. Ed: Timothy G. Murray, Future Medicine, 1st edition.

Houston SK, Murray TG. Chapter 9: Retinoblastoma treatment. Retinoblastoma: Clinical advances and emerging treatment strategies. Ed: Timothy G. Murray, Future Medicine, 1st edition.

Houston SK, Boldt HC, Murray TG. Chapter 10: Brachytherapy for uveal melanoma. Ocular melanoma: advances in diagnostic and therapeutic strategies. Ed: Timothy G. Murray and Culver Boldt, Future Medicine, 1st edition.

Houston SK, Murray TG. Chapter 17: Surgical management of radiation-related complications. Ocular melanoma: advances in diagnostic and therapeutic strategies. Ed: Timothy G. Murray and Culver Boldt, Future Medicine, 1st edition.

List of Publications by Elias C. Mavrofrides, MD

“Indocyanine Green-Assisted Internal Limiting Membrane Peeling for Macular Holes: Toxicity?” Mavrofrides, E., Smiddy WE, Kitchens JW, Salicone A, Feuer W. Retina. 2006 July-Aug; 26(6):637-44.

“Extended Endotamponade with Perfluoro-n-Octane in Pediatric Retinal Detachment” Sisk RA, Berrocal AM, Murray TG, Mavrofrides EC. Ophthalmic Surg Lasers Imaging, 2010.

“Treatment of Choroidal Neovascularization Associated with Best’s Disease.” Rich R, Vanderveldt S, Berrocal AM, Mavrofrides EC, Murray TG, Gregori N. Pediatric Strabismus 2009, Sept-Oct.

“Anterior Segment Ischemia Following Laser Therapy for Threshold Retinopathy of Prematurity.” Gaitan JR, Berrocal AM, Murray TG, Hess D, Johnson RA, Mavrofrides EC. Retina, 2008.

“Retinal Breaks Observed During Pars Plana Vitrectomy.” Moore JK, Kitchens JW, Smiddy WE, Mavrofrides EC, Gregorio G. American Journal of Ophthalmology, 2007, July.

“One-year Safety and Efficacy of Intravitreal Triamcinolone Acetonide for the Management of Macular Edema Secondary to Central Retinal Vein Occlusion.” Gregori NZ, Rosenfeld PJ, Puliafito, CA, Flynn HW Jr, Lee JE, Mavrofrides EC, Smiddy WE, Murray TG, Berrocal AM, Scott IU, Gregori G. Retina, 2006.

“Development of Multiple Subretinal Hemorrhages During Diode Laser Supplementation for Retinopathy of Prematurity.” Mavrofrides EC, Berrocal AM, Murray TG. Journal of Pediatric Ophthalmology & Strabismus, 2006 Mar-Apr.

“Progression of Familial Exudative Vitreoretinopathy After Laser Treatment.” Margolis R, Couvillion SS, Mavrofrides EC, Hess D, Murray TG. Archives of Ophthalmology, 2004, Nov.

“Clinical Applications of Optical Coherence Tomography for the Diagnosis and Management of Macular Diseases.” Voo I, Mavrofrides EC, Puliafito CA. Ophthalmology Clinics of North America, 2004, Mar.

Bascom Palmer Grand Rounds. Mavrofrides, E.C.; Co-Editor; Ophthalmology Times. Advanstar Publishing. Cleveland, OH. 2003- 2004

“Endophthalmitis Caused by Proteus Species.” Mavrofrides, E.C., Scott, I.U., Flynn, H.W Jr., Miller D. Accepted for publication. Ophthalmology, 2004.

“Progression of Familial Exudative Vitreoretinopathy after Laser Treatment.” Couvillion, S.S., Margolis, R.M., Mavrofrides, E.C., Murray, T.G. Accepted for publication. Archives of Ophthalmology, 2004.

“Vitreoretinal Interface Disorders.” Mavrofrides, E.C., Rogers, A.H., Truong, S., Puliafito, C.A. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004.

“Central Serous Chorioretinopathy.” Mavrofrides, E.C., Puliafito, C.A. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004.

“Miscellaneous Macular Degeneration.” Mavrofrides, E.C., Puliafito, C.A. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004.

“Macular Degenerations.” Villate, N., Mavrofrides, E.C., Rosenfeld, P. In: Schuman, J.S., Puliafito, C.A., Fugimoto, J.G. Optical Coherence Tomography of Ocular Disease, Second Edition. Slack, Inc. Publication pending, 2004.

“Patient Complains of Dimming Vision in Both Eyes- She is referred for Unexplained Vision Loss after Extensive Evaluation is Negative.” Mavrofrides, E.C., Lam, B., Bascom Palmer Eye Institute Grand Rounds, edited by CWG Eifrig, M Benz. Ophthalmology Times, 2003; 28: 14-16, 2003.

Baylor Ophthalmology Resident’s Manual: Editor. Baylor College of Medicine, Department of Ophthalmology- Cullen Eye Institute, Houston, Texas. 2001.

“ROP Screening and Treatment at Jackson Memorial Hospital/Bascom Palmer Eye Institute Over a 13 month period.” Mavrofrides, E.C., Berrocal, A.M., Hess, D., Johnson, R.A., Murray, T.G. Presented at the Third International Symposium on ROP. Anaheim, CA. 2003

“Persistent Neovascularization after Laser Photocoagulation for Threshold Retinopathy of Prematurity.” Mavrofrides, E.C., Berrocal, A.M., Hess, D., Johnson, R.A., Murray, T.G. Presented at the Third International Symposium on ROP. Anaheim, CA. 2003.

“RetCam Digital Imaging in the Screening and Management of ROP. Mavrofrides, E.C., Berrocal, A.M., Hess, D., Johnson, R.A., Murray, T.G. Presented at the Third International Symposium on ROP. Anaheim, CA. 2003

“Endophthalmitis Caused by Proteus Species.” Mavrofrides, E.C., Flynn, H.W. Jr., Scott, I.U., Miller, D. Presented at the Annual ARVO National Meeting. Ft. Lauderdale, FL. 2003

“Pilot Study of Intravitreal Injection of Tiamcinolone Acetonide for Refractive Diabetic Macular Edema.” Park, P.W., Mavrofrides, E.C., Holz, E.R., Mieler, W.F. Presented at the Annual ARVO National Meeting. Ft. Lauderdale, FL. 2003

“Intravitreal Triamcinolone for Refractory Diabetic Macular Edema.” Mavrofrides, E.C., Bailey, K., Holz, E.R., Mieler, W.F. Presented at the Baylor Ophthalmology Alumni Association Annual Meeting. Houston, Texas. 2002.

“Lasik for the Treatment of Mixed Astigmatism-Visual Outcomes and Topographic Analysis.” Mavrofrides, E.C., Wang, N., Wang, L, Koch D.D. Presented at the Baylor Ophthalmology Alumni Association Annual Meeting. Houston, Texas. 2001.

“Ocular Agyrosis – A Case Report and Literature Review.” Mavrofrides, E.C., Wilhelmus, K.R. Presented at the Baylor Ophthalmology Alumni Association Annual Meeting. Houston, Texas. 2000.

List of Publications by Doctor Raul J. Moreno, MD

“Effect of Succinylcholine on the Intraocular Contents of Open Globes.” Moreno, R.J., Kloess, P., Carlson, D.W.; Ophthalmology 1991, 98: 636-638

“Neuroretinitis: An Unusual Presentation of Ocular Taxoplasmosis. Moreno, R.J., Weisman, J., Waller, S. Accepted for Publication, Annals of Ophthalmology

In Response: Letter to the Editor, Ophthalmology, November, 1991.

“Unusual Manifestations of X Linked Juvenile Retinoschisis.” Greven, C.M., Moreno, R.J., Tasman, W. Accepted for Publication, Transactions of the American Ophthalmological Society

“Flurbiprofen Sodium to Prevent Intraoperative Miosis During Vitreoretinal Surgery.” Vander, J.F., Greven, C.M., Maquire, J., Moreno, R.J., Shakin, C.P., Lucier, A.C., Amercian Journal of Ophthalmology, 1, 2008: 288-291, 1989

Book Chapters

"Retinopathy of Prematurity," McNamara Arch, Raul Moreno, Tasman, William, For Duane's Clinical Text.

Presentations

Instructor: Academy Course on Laser Transfer, 1993, Dallas, Texas

Unusual Case of Central Ritinial Artery Occlusion: Mayo Clinic Fluorescein Conference, November, 1991, Jacksonville, Florida.

Instructor: Academy Course given by James Tiedeman on Uses of Lasers on the Retina, 1990, Atlanta, Georgia.

Choroidal Melanoma: Overall View. Grand Rounds, University of Texas Health Science Center, 1990, San Antonio, Texas.

Current Concepts of Retinopathy of Prematurit, University of Texas Health Science Center, 1989, San Antonio, Texas.

Pseudo Melanoma as Complications of Central Retinal Vein Occlusion, Wills Eye Hospital Annual Fluorescein Conference, 1988, Philadelphia, Pennsylvania.

Ocular Manifestations of Ring 10 Chromosome, Alamo City Resident's Day, 1985, San Antonio, Texas.

Tonometry in Partial Gas Filled Eyes. Alamo City Resident's Day, 1985, San Antonio, Texas.

Pulmonary Function Tests in Patients Undergoing Chronic Hemodialysis, American College of Physicians Regional Meeting, 1981, Mayaguez, Puerto Rico.

Posters

The Use of Hyperbaric Oxygen in Chronic Cystoid Macular Secondary to Central Retinal Vein Occlusion, 1991.

Effect of Succinylcholine on the Intraocular Contents of Open Globes, ARVO, 1991.

List of Publications by Doctor James A. Staman, MD

“EOG and Choroidal Melanomas.” Documenta Ophthalmologica, 1979

“Surgical Correction of Circumferential Folds of Giant Tears.” Retina, Volume 1, Number 1, 1980